Diabetes Mellitus — Core Principles
Core Principles
Diabetes Mellitus is a chronic condition marked by high blood sugar (hyperglycemia) due to problems with insulin, a hormone from the pancreas. Insulin helps glucose enter cells for energy. In Type 1 Diabetes, the body's immune system destroys insulin-producing cells, leading to absolute insulin deficiency, requiring lifelong insulin injections.
Type 2 Diabetes, more common, involves insulin resistance (cells don't respond well to insulin) and/or insufficient insulin production. It's often linked to lifestyle and genetics. Gestational Diabetes occurs during pregnancy.
Common symptoms include increased urination (polyuria), thirst (polydipsia), and hunger (polyphagia). Diagnosis involves blood tests like Fasting Plasma Glucose, Oral Glucose Tolerance Test, and HbA1c.
Untreated diabetes can lead to severe complications affecting eyes, kidneys, nerves, and heart. Management focuses on lifestyle changes and medications, including insulin or oral hypoglycemic agents, to maintain blood glucose levels within a healthy range and prevent long-term damage.
Important Differences
vs Type 1 Diabetes Mellitus vs. Type 2 Diabetes Mellitus
| Aspect | This Topic | Type 1 Diabetes Mellitus vs. Type 2 Diabetes Mellitus |
|---|---|---|
| Primary Defect | Absolute insulin deficiency due to autoimmune destruction of pancreatic beta cells. | Insulin resistance (cells don't respond to insulin) and progressive beta-cell dysfunction (relative insulin deficiency). |
| Onset | Typically acute, often in childhood or adolescence (juvenile diabetes). | Typically gradual, often in adulthood (adult-onset diabetes), but increasingly seen in younger individuals. |
| Etiology | Autoimmune, genetic predisposition, environmental triggers (e.g., viral infections). | Genetic predisposition, strong association with lifestyle factors (obesity, physical inactivity, unhealthy diet). |
| Insulin Production | Very low or absent endogenous insulin production. | Initially normal or high insulin production (hyperinsulinemia) to compensate for resistance, eventually declines. |
| Ketosis/DKA Risk | High risk of diabetic ketoacidosis (DKA) due to severe insulin deficiency. | Low risk of DKA, but hyperosmolar hyperglycemic state (HHS) is possible. |
| Treatment | Lifelong exogenous insulin therapy is essential for survival. | Lifestyle modifications, oral hypoglycemic agents, sometimes insulin therapy as disease progresses. |
| Body Weight | Often normal or underweight at diagnosis. | Often overweight or obese at diagnosis. |